Browse studies

Find your next paid study

3,219 recruiting studies matching your filters

Expanding Access to Cognitive Health Biomarker Testing at Home

The goal of this observational study is to learn whether at-home blood biomarker testing for Alzheimer's disease risk is feasible and acceptable in older adult…

Mild Cognitive Impairment (MCI)Alzheimer's Dementia (AD)Subjective Cognitive Decline (SCD)+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of VirginiaNCT07594665

Phase 2

A Phase II Study of ACR-368 and Low Dose Gemcitabine Combination Therapy in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

The purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Sq…

Head and Neck Squamous Cell Carcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

H. Lee Moffitt Cancer Center and Research InstituteNCT06597565

Phase 1

A Seamless Phase 1/2 Open-label Study to Evaluate the Safety, Determine the Maximum Tolerated Dose of Administered Activity, and Evaluate the Efficacy of the Therapeutic Radiopharmaceutical [Ac 225]-RTX-2358 in the Treatment of Relapsed or Refractory Sarcoma

The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio …

Advanced Soft Tissue Sarcoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ratio Therapeutics, Inc.NCT07156565

Blue Light Cystoscopy With Cysview® Registry

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Bladder Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

PhotocureNCT02660645

Observational

Cardiometabolic Risk Effects of Short-term Cessation of Effective Neurostimulation Therapy in OSA

Hypoglossal nerve stimulation (HGNS) is an implantable therapy that treats obstructive sleep apnea. The study will evaluate the effect of this treatment on ca…

Obstructive Sleep ApneaObstructive Sleep Apnea of Adult

Estimated

~$10 – $750

Actual pay is set by the research site.

Columbia UniversityNCT06720545

Phase 1

A Pilot Study of Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

This research is being done to investigate the safety and effectiveness of Darzalex Faspro (daratumumab and hyaluronidase-fihj) (a monoclonal antibody that tar…

Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1

Phase 1/2 Open Label, Safety and Preliminary Efficacy Study of a Live Biotherapeutic Product (CJRB-101) in Combination With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Study CJB-101-01 will be conducted at multiple centers in the USA and Republic of Korea as an open-label safety and preliminary efficacy study of CJRB-101 in c…

NSCLCHNSCCMelanoma+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

CJ Bioscience, Inc.NCT05877430

Phase 2

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients …

Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+12 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

Phase 4

Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery

We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which in…

Laparoscopic Adnexal Surgery

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of TennesseeNCT06842771

Phase 1

Phase 1b Dose Escalation Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast activation protein (FAP) antibody-drug conjugate (ADC), in combination with gemcitabine…

Pancreatic Adenocarcinoma Metastatic

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Oncomatryx Biopharma S.L.NCT07377045

Phase 2

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (Tocilizumab) for the Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) J…

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Nationwide Children's HospitalNCT05233397

Phase 1

A Phase 1b/II Study of Intratumoral CD40 Agonist 2141-V11 in Combination With Anti PD-1 and 5-Fluorouracil Therapy in Patients With Advanced Gastroesophageal Adenocarcinoma

The purpose of this study is to find out whether adding the drug 2141-V11 to standard treatment (anti-PD-1 immunotherapy with or without 5-FU) is a safe treatm…

Esophageal CancerAdvanced Esophageal CancerGastric Cancer+5 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07818018